US2007015171A1PendingUtilityA1

Non-invasive method for isolation and detection of fetal DNA

Assignee: CHILDRENS HOSP MEDICAL CENTERPriority: Nov 13, 1989Filed: Nov 17, 2005Published: Jan 18, 2007
Est. expiryNov 13, 2009(expired)· nominal 20-yr term from priority
Inventors:Diana Bianchi
G01N 33/80C12Q 1/6804C12Q 1/6806C12Q 1/6841C12Q 1/686C12Q 1/6876C12Q 1/6879C12Q 1/6881C12Q 1/6883G01N 33/5002G01N 33/56966G01N 33/56972G01N 33/56977C12Q 2600/156G01N 2015/1006
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method of detecting the presence or absence of the fetal DNA sequence of interest in fetal DNA derived from a sample of peripheral blood obtained from a pregnant woman is described. The method involves obtaining a sample peripheral blood from a pregnant woman, treating the sample of peripheral blood such that the fetal DNA present in the fetal nucleated cells is made available for detection and detecting the presence or absence of the fetal DNA sequence of interest in the available fetal DNA. The proportion of fetal nucleated cells present in the sample of peripheral blood can be increased forming a sample enriched in fetal nucleated cells prior to the detection step. The fetal DNA sequence of interest can be detected by treating the peripheral blood sample such that fetal DNA present in the sample is made available for hybridization with a DNA probe and subsequently contacting the available fetal DNA with a DNA probe hybridizable to fetal DNA of interest under hybridization conditions. The presence or absence of hybridization between the DNA probe and the fetal DNA of interest is detected as an indication of the presence or absence of the fetal DNA of interest.

Claims

exact text as granted — not AI-modified
1 . A method of detecting the presence or absence of a fetal DNA sequence of interest in fetal DNA derived from a sample of peripheral blood obtained from a pregnant woman, comprising: 
 obtaining a sample of peripheral blood from a pregnant woman;    treating the sample of peripheral blood such that fetal DNA present in fetal nucleated cells present in the sample is made available for detection resulting in available fetal DNA; and    detecting the presence or absence of a fetal DNA sequence of interest in the available fetal DNA.    
   
   
       2 - 45 . (canceled)

Join the waitlist — get patent alerts

Track US2007015171A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.